ResMed Inc.
RMD Real Time Price USD$RMD is featured in our Tom Carper strategy.
All StrategiesRecent trades of RMD by members of U.S. Congress
---
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in RMD holdings by institutional investors
Quarterly net insider trading by RMD's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$20,000 Oct 14, 2026 Issue: Manufacturing Medical/Disease Research/Clinical Labs Health Issues Veterans
-
$110,000 Jul 20, 2026 Issue: Tariff (miscellaneous tariff bills) Health Issues Medicare/Medicaid
-
$30,000 Jul 09, 2026 Issue: Manufacturing Medical/Disease Research/Clinical Labs Veterans Health Issues
-
$40,000 Apr 20, 2026 Issue: Manufacturing Medical/Disease Research/Clinical Labs Veterans Health Issues
-
$110,000 Apr 20, 2026 Issue: Tariff (miscellaneous tariff bills)
-
$40,000 Jan 20, 2026 Issue: Manufacturing Medical/Disease Research/Clinical Labs Veterans Health Issues
-
$90,000 Jan 20, 2026 Issue: Medicare/Medicaid Health Issues Tariff (miscellaneous tariff bills)
-
$20,000 Oct 20, 2025 Issue: Medicare/Medicaid
-
$40,000 Oct 16, 2025 Issue: Health Issues
-
$60,000 Jul 21, 2025 Issue: Health Issues
-
$60,000 Apr 21, 2025 Issue: Health Issues
-
$60,000 Jan 21, 2025 Issue: Health Issues
-
$60,000 Oct 21, 2024 Issue: Health Issues
-
$40,000 Jul 22, 2024 Issue: Health Issues
-
$40,000 Jan 19, 2024 Issue: Medicare/Medicaid
-
$40,000 Oct 20, 2023 Issue: Medicare/Medicaid
-
$40,000 Jul 20, 2023 Issue: Medicare/Medicaid
-
$50,000 Jan 20, 2023 Issue: Health Issues
-
$30,000 Nov 09, 2022 Issue: Health Issues
-
$50,000 Oct 20, 2022 Issue: Health Issues Medicare/Medicaid
-
$20,000 Oct 19, 2022 Issue: Health Issues
-
$150,000 Aug 10, 2022 Issue: Health Issues
-
$180,000 Jul 28, 2022 Issue: Health Issues
-
$180,000 Jul 28, 2022 Issue: Health Issues
-
$30,000 Jul 20, 2022 Issue: Medicare/Medicaid
-
$40,000 Feb 09, 2022 Issue: Medicare/Medicaid Health Issues
-
$40,000 Oct 20, 2021 Issue: Medicare/Medicaid
-
$40,000 Jul 20, 2021 Issue: Health Issues Medicare/Medicaid
-
$40,000 Apr 20, 2021 Issue: Medicare/Medicaid Health Issues
-
$50,000 Jan 20, 2021 Issue: Medicare/Medicaid Health Issues
-
$60,000 Oct 20, 2020 Issue: Health Issues Medicare/Medicaid
-
$40,000 Jul 20, 2020 Issue: Medicare/Medicaid Health Issues
-
$30,000 Apr 20, 2020 Issue: Health Issues
-
$60,000 Jan 20, 2020 Issue: Health Issues
-
$60,000 Oct 20, 2019 Issue: Health Issues
-
$140,000 Jul 22, 2019 Issue: Health Issues
-
$70,000 Apr 22, 2019 Issue: Health Issues
-
$60,000 Jan 22, 2019 Issue: Health Issues
-
$70,000 Oct 22, 2018 Issue: Health Issues
-
$70,000 Jul 20, 2018 Issue: Health Issues
-
$80,000 Apr 19, 2018 Issue: Health Issues
-
$20,000 Jan 22, 2018 Issue: Medicare/Medicaid
-
$60,000 Jan 18, 2018 Issue: Health Issues
-
$10,000 Oct 19, 2017 Issue: Medicare/Medicaid
-
$60,000 Oct 16, 2017 Issue: Health Issues
-
$10,000 Jul 28, 2017 Issue: Medicare/Medicaid
-
$60,000 Jul 20, 2017 Issue: Health Issues
-
$60,000 Apr 19, 2017 Issue: Health Issues
-
$20,000 Apr 19, 2016 Issue: Health Issues
-
$10,000 Oct 08, 2009 Issue: Medicare/Medicaid
-
$10,000 Jul 07, 2009 Issue: Medicare/Medicaid
-
$10,000 Apr 14, 2009 Issue: Medicare/Medicaid
-
$10,000 Jan 19, 2009 Issue: Medicare/Medicaid
-
$10,000 Oct 13, 2008 Issue: Medicare/Medicaid
-
$15,000 Jul 15, 2008 Issue: Medicare/Medicaid
-
$15,000 Apr 14, 2008 Issue: Medicare/Medicaid
-
$80,000 Feb 13, 2006 Issue: Health Issues
-
$120,000 Aug 12, 2005 Issue: Health Issues
-
$100,000 Feb 17, 2005 Issue: Health Issues
Former government officials who have lobbied for RMD
18 former government officials from 11 congressional offices at 4 lobbying firms have lobbied for RMD, most recently Oct 14, 2026.
-
Michael Heaton House Former Legislative Director for Congressman Mike Turner (R-OH) -
Anna Abram Senate New Dpty Comm, Pol, Leg, Intnl Affrs, FDA, Mar19Jan21; Mar17Mar19; Spcl Asst HHS, Jan21Mar17; Dec09Jan21; Hlth Dirctr, Sen Burr, Sen Hlth, L&P Comm, Apr09Dec09; Stff Mbr, Sen VA Comm, Feb09Apr09; AsstDrctr, WH Jan0709; LA, LC, SA, SenSantorum, May03Dec06 -
Tim Day House Chief of Staff - Former Congresswoman Deborah Pryce -
Michael Heaton House Former Legislative Director for Congressman Mike Turner (R-OH)
-
Michael Stroud House Deputy Chief Counsel House of Representatives Homeland Security Committee; Deputy Assistant Secretary Legislative Affairs, U.S. Department of Homeland Security; Assistant Secretary Private Sector Office (Acting), U.S. Department of Homeland Security
-
Ryan Jarmula House Chief of Staff - Former Congressman Greg Pence; Deputy Chief of Staff/District Director - Former Congressman Greg Pence; White House Domestic Policy Council; Adviser for Policy Development and Speechwriting - Donald J. Trump -
Joseph Fawkner House New Snr Pol Adv for Rep. Carol D. Miller, Feb 20 - Jan 22. -
Shawn Bishop Senate New Chief Health Advisor, US Sen. Finance Comm. (2/16/21-11/15/2024); Senior Advisor, US Sen. Finance Comm. (5/6/19 - 10/1/19); Professional Staff, US Sen. Finance Comm. (2/5/2005-10/1/2010).
RMD Estimated quarterly lobbying spending
RMD Revenue by Segment or Geography
New RMD patent grants
-
Patent Title: Air delivery device Dec. 10, 2013
-
Patent Title: Mask assembly Dec. 03, 2013
-
Patent Title: Mask Nov. 26, 2013
-
Patent Title: Frame for respiratory mask Oct. 29, 2013
-
Patent Title: Cushion for respiratory mask Oct. 22, 2013
-
Patent Title: Adjustable forehead support dial for respiratory mask Oct. 15, 2013
-
Patent Title: Respiratory mask Oct. 15, 2013
-
Patent Title: Yoked headgear Sep. 17, 2013
-
Patent Title: Wearable positive airway pressure (pap) delivery device Aug. 27, 2013
-
Patent Title: Cushion for a respiratory mask Jul. 09, 2013
-
Patent Title: Respiratory mask Jun. 04, 2013
-
Patent Title: Cushion for respiratory mask May. 28, 2013
-
Patent Title: Forehead support frame component for a patient interface May. 07, 2013
-
Patent Title: Frame for a respiratory mask Apr. 30, 2013
-
Patent Title: Mask frame Apr. 09, 2013
-
Patent Title: Mask assembly Apr. 09, 2013
-
Patent Title: Humidifier tub for humidifier for positive airway pressure delivery device Apr. 02, 2013
-
Patent Title: Cushion for respiratory mask Mar. 26, 2013
-
Patent Title: Elbow component for a patient interface Mar. 26, 2013
-
Patent Title: Cuff with air delivery tube Mar. 12, 2013
-
Patent Title: Frame for respiratory mask Mar. 12, 2013
-
Patent Title: Adjustable forehead support dial for respiratory mask Mar. 12, 2013
-
Patent Title: Air delivery device Feb. 05, 2013
-
Patent Title: Frame for respiratory mask Jan. 29, 2013
-
Patent Title: Support for respiratory mask Jan. 01, 2013
-
Patent Title: Yoked headgear Dec. 25, 2012
-
Patent Title: Cushion for a respiratory mask Dec. 25, 2012
-
Patent Title: Cuff with air delivery tube Nov. 20, 2012
-
Patent Title: Forehead support for a mask Nov. 20, 2012
-
Patent Title: Respiratory mask frame Oct. 23, 2012
-
Patent Title: Headgear with pad for a respiratory mask Oct. 02, 2012
-
Patent Title: Respiratory mask Aug. 14, 2012
-
Patent Title: Cushion for respiratory mask Aug. 14, 2012
-
Patent Title: Mask Jul. 24, 2012
-
Patent Title: Headgear Jul. 10, 2012
-
Patent Title: Humidifier tub for humidifier for positive airway pressure delivery device Jul. 10, 2012
-
Patent Title: Headgear May. 22, 2012
-
Patent Title: Headgear pad for a respiratory mask May. 22, 2012
-
Patent Title: Yoked headgear May. 22, 2012
-
Patent Title: Patient interface May. 08, 2012
-
Patent Title: Positive airway pressure delivery device May. 08, 2012
-
Patent Title: Flow generator May. 01, 2012
-
Patent Title: Ventilator Apr. 24, 2012
-
Patent Title: Mask Apr. 17, 2012
-
Patent Title: Mask Mar. 27, 2012
-
Patent Title: Respiratory mask Mar. 20, 2012
-
Patent Title: Cuff for an air delivery tube Mar. 13, 2012
-
Patent Title: Vent for respiratory mask Mar. 13, 2012
-
Patent Title: Headgear for a respiratory mask Feb. 07, 2012
-
Patent Title: Cushion for respiratory mask Jan. 31, 2012
Federal grants, loans, and purchases
Estimated quarterly amount awarded to RMD from public contracts
Recent insights relating to RMD
Recent picks made for RMD stock on CNBC
ETFs with the largest estimated holdings in RMD
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $RMD stock a Buy, Sell, or Hold?
- What is the price target for $RMD stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $RMD stock?
- Who owns the most shares of $RMD stock?
- What funds own $RMD stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view RMD Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.
- Address San Diego, CA
- Market Cap 33.6 billion
- Employees 11,370
- Industrial Classification Surgical & Medical Instruments & Apparatus
ResMed Inc. (RMD) Historical Stock Prices
Daily open, high, low, close, adjusted close and volume for ResMed Inc. (RMD).
Quiver Premium charts RMD's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.
Upgrade to Premium| Date | Open | High | Low | Close | Adj. Close | Volume |
|---|
Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.
The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.
Explore the Quiver APIWe estimate that -- received a compensation of -- in --, making them the highest paid executive at RMD, per a recent SEC DEF 14A filing.
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|